Symbols

NMTC

NeuroOne Medical·NASDAQ

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 0

Ample Liquidity

High Gross Profit Margin

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About NMTC

Neuroone Medical Technologies Corporation

A medical technology company that develops and commercializes innovative neurodiagnostic and neuromodulation technologies

Industry

Healthcare Equipment and Supplies

Established Date

08/20/2009

Listing Date

05/26/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

09-30

Website

www.nmtc1.com

Security Type

Common stock

Office address

7599 Anagram Dr., Eden Prairie, MN 55344

Business

Introduction

NeuroOne Medical Technologies Corporation was incorporated under the laws of the State of Delaware on August 20, 2009. The company is a medical technology company focused on diagnosis, ablation and deep brain stimulation technologies for brain-related diseases such as epilepsy and Parkinson's disease; ablation and stimulation for systemic pain management; and drug delivery including diagnostic and stimulation capabilities.

Earnings Call

Q2/2025

Estimate EPS--

Actual EPS-0.07

Estimate Revenue1.27M

Actual Revenue1.40M

NeuroOne's Q2 2025: Unpacking Revenue Surprises and Margin Sustainability Amid Contradictions

May 20,2025 11:13·
Earnings Decrypt

Q3/2025

Estimate EPS--

Actual EPS-0.03

Estimate Revenue1.82M

Actual Revenue1.70M

NeuroOne's Q3 2025 Earnings Call: Key Contradictions in Product Development, Revenue, and FDA Pathways

Aug 14,2025 09:50·
Earnings Decrypt

Company Financials

EPS

NMTC has released its 2025 Q4 earnings. EPS was reported at -0.03, versus the expected -0.04, beating expectations. The chart below visualizes how NMTC has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

NMTC has released its 2025 Q4 earnings report, with revenue of -259.07K, reflecting a YoY change of -195.15%, and net profit of -1.62M, showing a YoY change of 51.67%. The Sankey diagram below clearly presents NMTC's revenue sources and cost distribution.